The last few months of 2023 hold the potential to bring important updates in cancer, brain and blood disease research, starting later this week with the European Society of Medical Oncology’s annual congress.
Next week’s Clinical Trials on Alzheimer’s Disease meeting will feature fresh data for the field’s most closely watched drugs, while the American Society of Hematology’s conference in December is set to take place after a Food and Drug Administration decision on what could be an important new sickle cell disease treatment.
Already, conference organizers have lined up meeting dates for next year. BioPharma Dive has collected the schedules and locations of key medical and industry events remaining in 2023 and scheduled in 2024:
